TY  - BOOK
AU  - Prasad,Vinayak K.
TI  - Malignant: how bad policy and bad evidence harm people with cancer 
SN  - 9781421437644
AV  - RC271 .M355 2020
PY  - 2020///
CY  - Baltimore
PB  - Johns Hopkins University Press
KW  - Cancer
KW  - Chemotherapy
KW  - United States
KW  - Antineoplastic agents
KW  - Economic aspects
KW  - Medicine
KW  - Research
KW  - Drug development
KW  - Medical policy
KW  - Patients
KW  - Civil rights
KW  - Neoplasms
KW  - drug therapy
KW  - Antineoplastic Agents
KW  - economics
KW  - Biomedical Research
KW  - Drug Development
KW  - Health Policy
KW  - Patient Rights
KW  - Electronic Books
N1  - 2; The Basics of Cancer Drugs : Cost, Benefit, Value --; Surrogate Endpoints in Cancer : What Are They and Where Are They Used? --; Use and Misuse of Surrogates for Drug Approvals --; How High Prices Harm Patients and Society --; Hype, Spin, and the Unbridled Enthusiasm That Distorts Cancer Medicine --; Financial Conflict of Interest --; The Harms of Financial Conflicts and How to Rehabilitate Medicine --; Will Precision Oncology Save Us? --; Study Design --; Principles of Oncology Practice --; Important Trials in Oncology --; Global Oncology --; How Should Cancer Drug Development Proceed? --; What Can the US Food and Drug Administration and the Centers for Medicare and --; Medicaid Services Do Tomorrow? --; What Can People with Cancer Do? --; What Can Students, Residents, and Fellows Do?; 2; b
N2  - "In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"--
UR  - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2266298&site=eds-live&custid=s3260518
ER  -